Published October 09, 2026 · Compiled from the S-1/A filed on SEC EDGAR on 2026-10-09 and the Quintarthai IPO calendar. Quoted passages are the filing's own words.

City Therapeutics, Inc. (CTY) IPO: what the S-1/A filing says

City Therapeutics, Inc. filed an S-1/A with the SEC on 2026-10-09 in connection with its US listing.

In the Quintarthai IPO calendar: status Upcoming, exchange NASDAQ, expected listing date Oct 16, 2026.

Use of proceeds (quoted from the filing)

• “Our expected use of the net proceeds from this offering represents our intentions based on our current plans and business conditions.”
• “As of the date of this prospectus, we cannot predict with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering or the amounts that we will actually spend on the uses set forth above.”

Source: S-1/A on SEC EDGAR · IPO research page: CTY.

Research and analysis only — not investment advice, not a recommendation to apply or avoid.